Lisa D. Belmont
Exelixis (United States)(US)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Multiple Myeloma Research and Treatments, Peptidase Inhibition and Analysis, Protein Degradation and Inhibitors, Cancer Mechanisms and Therapy
Most-Cited Works
- → Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7(2011)808 cited
- → Identification of a Protein That Interacts with Tubulin Dimers and Increases the Catastrophe Rate of Microtubules(1996)665 cited
- → Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy(2015)535 cited
- → Real-time visualization of cell cycle-dependent changes in microtubule dynamics in cytoplasmic extracts(1990)447 cited
- → Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models(2016)308 cited
- → Antitumor activity of an allosteric inhibitor of centromere-associated protein-E(2010)254 cited
- → Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development(2018)241 cited
- → Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells(2012)190 cited
- → A change in actin conformation associated with filament instability after P i release(1999)161 cited
- → AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs(2014)145 cited